Articles

Search Articles

Advanced search
Help

Catalogue

Articles

Databases

X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (3511) 3511
Publication (164) 164
Newsletter (90) 90
Magazine Article (18) 18
Newspaper Article (16) 16
Dissertation (10) 10
Book Review (7) 7
Web Resource (4) 4
Book Chapter (2) 2
Paper (2) 2
Trade Publication Article (2) 2
Conference Proceeding (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
ramipril (2195) 2195
humans (1891) 1891
male (1550) 1550
female (1076) 1076
angiotensin-converting enzyme inhibitors - therapeutic use (1059) 1059
ramipril - therapeutic use (1038) 1038
middle aged (857) 857
animals (760) 760
index medicus (756) 756
hypertension (688) 688
hypertension - drug therapy (677) 677
aged (662) 662
angiotensin-converting enzyme inhibitors - pharmacology (616) 616
ramipril - pharmacology (598) 598
blood pressure - drug effects (591) 591
cardiac & cardiovascular systems (561) 561
rats (555) 555
adult (511) 511
pharmacology & pharmacy (492) 492
antihypertensive agents - therapeutic use (479) 479
peripheral vascular disease (467) 467
treatment outcome (426) 426
ramipril - administration & dosage (355) 355
risk factors (349) 349
drug therapy, combination (342) 342
medicine, general & internal (300) 300
ace inhibitors (296) 296
double-blind method (288) 288
hypertension - physiopathology (278) 278
mortality (275) 275
angiotensin-converting enzyme inhibitors - administration & dosage (270) 270
blood-pressure (253) 253
blood pressure (246) 246
captopril (245) 245
telmisartan (240) 240
angiotensin-converting enzyme inhibitors (232) 232
prevention (232) 232
time factors (229) 229
angiotensin (227) 227
angiotensin-converting enzyme inhibitors - adverse effects (226) 226
urology & nephrology (224) 224
ramipril - adverse effects (216) 216
drug therapy (210) 210
risk (210) 210
research (198) 198
cardiovascular diseases - prevention & control (197) 197
heart-failure (195) 195
randomized controlled trials as topic (192) 192
diabetes (188) 188
disease (186) 186
renin-angiotensin system - drug effects (186) 186
prospective studies (183) 183
cardiovascular events (181) 181
enalapril (181) 181
ramipril - analogs & derivatives (180) 180
follow-up studies (179) 179
dose-response relationship, drug (176) 176
antihypertensive agents - pharmacology (172) 172
benzimidazoles - therapeutic use (171) 171
hypertension - complications (171) 171
bradykinin (168) 168
antihypertensive agents - administration & dosage (164) 164
angiotensin ii type 1 receptor blockers - therapeutic use (163) 163
trial (163) 163
renin-angiotensin system (157) 157
myocardial-infarction (155) 155
losartan (154) 154
benzoates - therapeutic use (147) 147
heart failure (144) 144
rats, sprague-dawley (140) 140
analysis (136) 136
angiotensin-converting enzyme (134) 134
enzymes (133) 133
bradykinin - pharmacology (130) 130
proteinuria (128) 128
cardiovascular diseases (126) 126
care and treatment (125) 125
heart failure - drug therapy (125) 125
nephropathy (125) 125
progression (121) 121
rats, inbred shr (121) 121
clinical trials as topic (120) 120
bridged bicyclo compounds - pharmacology (119) 119
cardiovascular disease (117) 117
health aspects (117) 117
cardiovascular diseases - drug therapy (116) 116
antihypertensive agents - adverse effects (114) 114
therapy (114) 114
rats, wistar (113) 113
dosage and administration (112) 112
aged, 80 and over (111) 111
disease progression (108) 108
stroke (108) 108
valsartan (108) 108
atherosclerosis (107) 107
medicine & public health (107) 107
hemodynamics - drug effects (105) 105
myocardial infarction - drug therapy (105) 105
myocardial infarction (104) 104
outcomes (103) 103
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (3223) 3223
German (166) 166
Russian (82) 82
French (56) 56
Spanish (24) 24
Chinese (18) 18
Hungarian (16) 16
Italian (14) 14
Polish (12) 12
Japanese (7) 7
Portuguese (7) 7
Croatian (6) 6
Czech (5) 5
Turkish (3) 3
Ukrainian (3) 3
Dutch (2) 2
Korean (2) 2
Lithuanian (2) 2
Swedish (2) 2
Danish (1) 1
Finnish (1) 1
Hebrew (1) 1
Norwegian (1) 1
Serbian (1) 1
Slovak (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


1. Full Text Priminary observations of the effects of ACE inhibitor ramipril in patients with Stargardt's disease
by REKIK, R and CHARFEDDINE, R
Acta Ophthalmologica, ISSN 1755-375X, 09/2012, Volume 90
Purpose to assess the effect of Ramipril 2% eyedrops on visual function in patients with Stargardt’s disease. Methods We conducted a prospective,... 
Ramipril
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
2. Full Text Development and bioavailability assessment of ramipril nanoemulsion formulation
by Shafiq, Sheikh and Shakeel, Faiyaz and Talegaonkar, Sushma and Ahmad, Farhan J and Khar, Roop K and Ali, Mushir
European Journal of Pharmaceutics and Biopharmaceutics, ISSN 0939-6411, 2007, Volume 66, Issue 2, pp. 227 - 243
The objective of our investigation was to design a thermodynamically stable and dilutable nanoemulsion formulation of Ramipril, with minimum surfactant... 
Phase diagrams | SNEDDS | Nanoemulsion | Solubility | Ramipril | Sefsol 218 | Bioavailability | PARTICLE-SIZE ANALYSIS | phase diagrams | FREQUENCY DIELECTRIC-SPECTROSCOPY | DOSAGE FORMS | nanoemulsion | ORAL ABSORPTION | ramipril | MICROEMULSION FORMULATION | SELF-EMULSIFICATION | bioavailability | IN-VIVO | solubility | ENHANCED ABSORPTION | PHARMACOLOGY & PHARMACY | POORLY SOLUBLE DRUGS | DRUG-DELIVERY SYSTEMS | Viscosity | Emulsions | Polysorbates - chemistry | Rats, Wistar | Biological Availability | Male | Angiotensin-Converting Enzyme Inhibitors - pharmacokinetics | Angiotensin-Converting Enzyme Inhibitors - blood | Phase Transition | Pharmaceutical Solutions | Ramipril - administration & dosage | Nanoparticles | Ramipril - blood | Thermodynamics | Capsules | Ethylene Glycols - chemistry | Drug Compounding | Oils - chemistry | Buffers | Administration, Oral | Drug Stability | Rats | Ramipril - pharmacokinetics | Technology, Pharmaceutical - methods | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Chemistry, Pharmaceutical | Angiotensin-Converting Enzyme Inhibitors - chemistry | Ramipril - chemistry | Animals | Models, Biological | Surface-Active Agents - chemistry | Hydrogen-Ion Concentration | Antihypertensive drugs | Analysis
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
3. Full Text Une atteinte musculaire severe au cours d'une sclerodermie systemique revelant un syndrome des antisynthetases a anti-PL 12
by Zaim, K and Kitane, Y.Y and Echchilali, K.K and Moudatir, M.M and Alaoui, F and Kabli, H. El
La Revue de medecine interne, ISSN 0248-8663, 06/2019, Volume 40, p. A148
Le syndrome des antisynthetases est une connectivite rare caracterisee par l'association d'atteintes cutanees, musculaires, pulmonaires interstitielles,... 
RNA | Ramipril
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
4. Full Text Medikamentose Therapie von Herzrhythmusstorungen
by Koller, Marcus L and Schumacher, Burghard
Medizinische Klinik, ISSN 0723-5003, 01/2010, Volume 105, Issue 1, p. 26
Ramipril
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
5. Full Text Ramipril and haloperidol as promising approaches in managing rheumatoid arthritis in rats
by Fahmy Wahba, Mariam Gamal and Shehata Messiha, Basim Anwar and Abo-Saif, Ali Ahmed
European Journal of Pharmacology, ISSN 0014-2999, 10/2015, Volume 765, pp. 307 - 315
Rheumatoid arthritis (RA) is a challenging autoimmune disorder, whose treatments usually cause severe gastrointestinal, renal and other complications. We aimed... 
Ramipril | Dexamethasone | Haloperidol | Rat | Methotrexate | Rheumatoid arthritis | ENZYME-INHIBITOR RAMIPRIL | COLLAGEN-INDUCED ARTHRITIS | OXIDATIVE STRESS | MATRIX PROTEIN | ANGIOTENSIN-II | ANTINUCLEAR ANTIBODIES | EXPERIMENTAL-MODELS | RECEPTOR ANTAGONIST | SYNOVIAL FIBROBLASTS | PHARMACOLOGY & PHARMACY | ADJUVANT ARTHRITIS | Rheumatoid Factor - blood | Arthritis, Experimental - drug therapy | Antirheumatic Agents - administration & dosage | Tumor Necrosis Factor-alpha - blood | Cartilage Oligomeric Matrix Protein - blood | Haloperidol - administration & dosage | Haloperidol - therapeutic use | Interleukin-10 - blood | Rats | Arthritis, Experimental - immunology | Biomarkers - blood | Arthritis, Rheumatoid - pathology | Ramipril - administration & dosage | Arthritis, Experimental - pathology | Animals | Arthritis, Rheumatoid - drug therapy | Female | Ramipril - pharmacology | Antirheumatic Agents - pharmacology | Ramipril - therapeutic use | Arthritis, Rheumatoid - immunology | Matrix Metalloproteinase 3 - blood | Haloperidol - pharmacology | Antirheumatic Agents - therapeutic use | Antioxidants | Rheumatoid factor | Enzymes | Pharmacy | Immunoglobulin G | Angiotensin | Drugstores | Arthritis | Interleukins | Central nervous system depressants | Angiotensin converting enzyme
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
6. Full Text Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial
by Mann, Johannes FE, Prof and Schmieder, Roland E, Prof and McQueen, Matthew, Prof and Dyal, Leanne, MSc and Schumacher, Helmut, MD and Pogue, Janice, PhD and Wang, Xingyu, PhD and Maggioni, Aldo, MD and Budaj, Andrzej, MD and Chaithiraphan, Suphachai, Prof and Dickstein, Kenneth, MD and Keltai, Matyas, Prof and Metsärinne, Kaj, MD and Oto, Ali, Prof and Parkhomenko, Alexander, MD and Piegas, Leopoldo S, MD and Svendsen, Tage L, MD and Teo, Koon K, Prof and Yusuf, Salim, Prof and ONTARGET Investigators and ONTARGET investigators
Lancet, The, ISSN 0140-6736, 2008, Volume 372, Issue 9638, pp. 547 - 553
Summary Background Angiotensin receptor blockers (ARB) and angiotensin converting enzyme (ACE) inhibitors are known to reduce proteinuria. Their combination... 
Internal Medicine | COOPERATE | MEDICINE, GENERAL & INTERNAL | METAANALYSIS | RENIN-ANGIOTENSIN SYSTEM | DISEASE | PROTEINURIA | CONVERTING ENZYME-INHIBITORS | COMBINATION | NEPHROPATHY | II RECEPTOR BLOCKERS | PROGRESSION | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Ramipril - administration & dosage | Proteinuria - chemically induced | Cardiovascular Diseases - complications | Glomerular Filtration Rate - drug effects | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Benzimidazoles - administration & dosage | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Angiotensin II Type 1 Receptor Blockers - administration & dosage | Benzimidazoles - therapeutic use | Kidney - drug effects | Double-Blind Method | Diabetes Mellitus - drug therapy | Proteinuria - metabolism | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Benzoates - administration & dosage | Creatinine - blood | Aged | Urine | Drugs | Studies | Kidneys | Disease | Clinical trials | Risk | ACE inhibitors | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
7. Full Text Strict Blood-Pressure Control and Progression of Renal Failure in Children
by Wühl, Elke and Trivelli, Antonella and Picca, Stefano and Litwin, Mieczyslaw and Peco-Antic, Amira and Zurowska, Aleksandra and Testa, Sara and Jankauskiene, Augustina and Emre, Sevinc and Caldas-Afonso, Alberto and Anarat, Ali and Niaudet, Patrick and Mir, Sevgi and Bakkaloglu, Aysin and Enke, Barbara and Montini, Giovanni and Wingen, Ann-Margret and Sallay, Peter and Jeck, Nikola and Berg, Ulla and Çaliskan, Salim and Wygoda, Simone and Hohbach-Hohenfellner, Katharina and Dusek, Jiri and Urasinski, Tomasz and Arbeiter, Klaus and Neuhaus, Thomas and Gellermann, Jutta and Drozdz, Dorota and Fischbach, Michel and Möller, Kristina and Wigger, Marianne and Peruzzi, Licia and Mehls, Otto and Schaefer, Franz and The ESCAPE Trial Group and ESCAPE Trial Group
The New England Journal of Medicine, ISSN 0028-4793, 10/2009, Volume 361, Issue 17, pp. 1639 - 1650
This study assessed the long-term renoprotective effect of intensified blood-pressure control among children receiving a fixed high dose of an... 
KIDNEY-DISEASE | GLOMERULAR-FILTRATION-RATE | MEDICINE, GENERAL & INTERNAL | RAMIPRIL | INSUFFICIENCY | FOLLOW-UP | PROTEINURIA | RANDOMIZED CONTROLLED-TRIAL | CONVERTING-ENZYME INHIBITOR | HYPERTENSION | NEPHROPATHY | Blood Pressure | Humans | Child, Preschool | Hypertension - drug therapy | Male | Renal Insufficiency, Chronic - complications | Hypertension - etiology | Ramipril - administration & dosage | Renal Insufficiency, Chronic - drug therapy | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Female | Drug Therapy, Combination | Ramipril - adverse effects | Child | Proteinuria - etiology | Glomerular Filtration Rate | Kaplan-Meier Estimate | Antihypertensive Agents - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - administration & dosage | Creatinine - urine | Renal Insufficiency, Chronic - physiopathology | Disease Progression | Kidney Failure, Chronic - prevention & control | Adolescent | Blood Pressure Monitoring, Ambulatory | Care and treatment | Kidney failure | Angiotensin converting enzyme | Blood pressure | Children | Management | Health aspects | Hypertension | Pediatrics | Kidney diseases | Index Medicus | Abridged Index Medicus
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
8. Full Text Telmisartan, Ramipril, or Both in Patients at High Risk for Vascular Events
by Yusuf, Salim and Teo, Koon K and Pogue, Janice and Dyal, Leanne and Copland, Ingrid and Schumacher, Helmut and Dagenais, Gilles and Sleight, Peter and Anderson, Craig and The ONTARGET Investigators and ONTARGET Investigators and Naturvetenskapliga fakulteten and Faculty of Sciences and Göteborgs universitet and Institutionen för cell- och molekylärbiologi and Gothenburg University and Department of Cell and Molecular Biology and Sahlgrenska Academy and Sahlgrenska akademin and Institutionen för medicin, avdelningen för akut och kardiovaskulär medicin and Institute of Medicine, Department of Emergeny and Cardiovascular Medicine
The New England Journal of Medicine, ISSN 0028-4793, 04/2008, Volume 358, Issue 15, pp. 1547 - 1559
This large trial compared the angiotensin-receptor blocker telmisartan, the angiotensin-converting–enzyme inhibitor ramipril, and combination therapy with both... 
MEDICINE, GENERAL & INTERNAL | DESIGN | LEFT-VENTRICULAR DYSFUNCTION | MYOCARDIAL-INFARCTION | CARDIOVASCULAR EVENTS | DOUBLE-BLIND | SYSTOLIC DYSFUNCTION | RANDOMIZED CLINICAL-TRIALS | CONGESTIVE-HEART-FAILURE | COMBINATION | CONVERTING-ENZYME-INHIBITORS | Benzoates - adverse effects | Angiotensin II Type 1 Receptor Blockers - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Angiotensin II Type 1 Receptor Blockers - therapeutic use | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Male | Risk | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - epidemiology | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Double-Blind Method | Diabetes Mellitus - drug therapy | Kaplan-Meier Estimate | Hospitalization | Creatinine - blood | Angioedema - chemically induced | Aged | Complications and side effects | Ramipril | Drug therapy, Combination | Diabetes | Cardiovascular diseases | Drug therapy | Comparative analysis | Risk factors | Telmisartan | Clinical trials | Vein & artery diseases | Cardiovascular disease | Pharmacology | Clinical outcomes | Index Medicus | Abridged Index Medicus | Blood Pressure | Benzimidazoles | Cardiovascular Diseases | MEDICIN OCH HÄLSOVETENSKAP | Angiotensin II Type 1 Receptor Blockers | epidemiology | Angiotensin-Converting Enzyme Inhibitors | Combination | MEDICAL AND HEALTH SCIENCES | Creatinine | chemically induced | Benzoates | drug therapy | Angioedema | drug effects | Diabetes Mellitus | blood | adverse effects | mortality | therapeutic use | Kaplan-Meiers Estimate
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights
9. Full Text Achieved blood pressure and cardiovascular outcomes in high-risk patients: results from ONTARGET and TRANSCEND trials
by Böhm, Michael, Prof and Schumacher, Helmut, PhD and Teo, Koon K, Prof and Lonn, Eva M, Prof and Mahfoud, Felix, MD and Mann, Johannes F E, Prof and Mancia, Giuseppe, Prof and Redon, Josep, Prof and Schmieder, Roland E, Prof and Sliwa, Karen, Prof and Weber, Michael A, Prof and Williams, Bryan, Prof and Yusuf, Salim, Prof
Lancet, The, ISSN 0140-6736, 2017, Volume 389, Issue 10085, pp. 2226 - 2237
Summary Background Studies have challenged the appropriateness of accepted blood pressure targets. We hypothesised that different levels of low blood pressure... 
Internal Medicine | MORTALITY | MEDICINE, GENERAL & INTERNAL | ONGOING TELMISARTAN | METAANALYSIS | RAMIPRIL | RATIONALE | DISEASE | TARGETS | COMBINATION | HYPERTENSIVE PATIENTS | ANTIHYPERTENSIVE TREATMENT | Benzoates - adverse effects | Benzoates - therapeutic use | Follow-Up Studies | Randomized Controlled Trials as Topic - methods | Cardiovascular Diseases - drug therapy | Humans | Middle Aged | Hospitalization - statistics & numerical data | Hypertension - drug therapy | Male | Multicenter Studies as Topic | Angiotensin-Converting Enzyme Inhibitors - therapeutic use | Hypotension - mortality | Angiotensin-Converting Enzyme Inhibitors - adverse effects | Cardiovascular Diseases - mortality | Female | Blood Pressure - drug effects | Ramipril - therapeutic use | Benzimidazoles - adverse effects | Drug Therapy, Combination | Ramipril - adverse effects | Benzimidazoles - therapeutic use | Cardiovascular Diseases - physiopathology | Antihypertensive Agents - therapeutic use | Hypotension - chemically induced | Hypertension - physiopathology | Antihypertensive Agents - adverse effects | Telmisartan | Hypotension - complications | Aged | Blood pressure | Hospitals | Research institutes | Germany | Myocardial infarction | Heart | Intervention | Syngeneic grafts | Funding | Medical services | Clinical trials | Cardiovascular disease | Blood | Optimization | Risk factors | Clinical outcomes | Incidence | Recruitment | Peptidyl-dipeptidase A | Risk assessment | Failure analysis | Pretreatment | Heart diseases | Hypertension | Cerebral infarction | Stroke | Risk groups | Adjustment | Categories | Mortality | Regression analysis | Patients | Variance analysis | Oral cavity | Inhibitors | Converting | Angiotensin | Death | Fatalities | Infarction | Cardiovascular diseases | Health risk assessment
Journal Article
Details down arrow
Digital rights down arrow
loading Loading Rights